The Vexed Relationship Between Clostridium Difficile and Inflammatory Bowel Disease: An Assessment of Carriage in an Outpatient Setting Among Patients in Remission

被引:161
作者
Clayton, Evelyn M. [1 ,2 ]
Rea, Mary C. [1 ,2 ]
Shanahan, Fergus [2 ]
Quigley, Eamonn M. M. [2 ]
Kiely, Barry [3 ]
Hill, Colin [2 ]
Ross, R. Paul [1 ,2 ]
机构
[1] Moorepark Food Res Ctr, Alimentary Pharmabiot Ctr, Cork, Fermoy Co, Ireland
[2] Natl Univ Ireland, Cork, Ireland
[3] Alimentary Hlth, Cork, Ireland
基金
爱尔兰科学基金会;
关键词
BINARY TOXIN; ANTIMICROBIAL SUSCEPTIBILITY; PATHOGENICITY LOCUS; SPACER REGIONS; PULSED-FIELD; STRAINS; TCDC; ELECTROPHORESIS; POLYMORPHISM; TOXINOTYPES;
D O I
10.1038/ajg.2009.4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVES: Comorbidity with Clostridium difficile may cause diagnostic delay in newly presenting inflammatory bowel disease (IBD) patients, trigger relapse in established disease, confound therapies, and serve as an indicator of an underlying defect in innate immunity. Retrospective analyses have suggested community acquisition; to address this we conducted a prospective analysis of C. difficile carriage in IBD patients using molecular methods specifically in an outpatient setting. METHODS: Recruited participants had long-standing diagnoses of ulcerative colitis (n = 64) and Crohn's disease (n = 58), were in clinical remission, and had no recent exposure to antibiotics, corticosteroids, immunomodulatory drugs or recent hospitalization. Isolates were cultured from stools and confirmed by 16S sequencing. The antibiotic susceptibilities of the isolates were tested followed by further strain characterization by toxinotyping, ribotyping, and pulsed-field gel electrophoresis (PFGE). RESULTS: The frequency of toxigenic C. difficile was higher in IBD patients than in healthy volunteers at 8.2 and 1.0%, respectively (P = 0.02 Fisher's exact test). All strains belonged to toxinotype 0 with rare subtypes of this group noted in five isolates and represented by an altered repressor genotype. Patients harbored a diverse range of toxigenic ribotype groups, including those previously associated with C. difficile-associated disease (CDAD) (R015, R005, and R020) and the rarer types R062, R050, and R003. Interestingly, common nosocomial groups were not identified. The considerable nonclonal distribution of distinct strains was further demonstrated by PFGE genomic fingerprinting. None of the study subjects experienced a clinical episode of CDAD during a 6-month period of follow-up. CONCLUSIONS: Detection of C. difficile is increased in IBD outpatients in remission, and strain diversity is consistent with community acquisition from a multitude of sources.
引用
收藏
页码:1162 / 1169
页数:8
相关论文
共 35 条
[1]   Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates [J].
Barbut, F. ;
Mastrantonio, P. ;
Delmee, M. ;
Brazier, J. ;
Kuijper, E. ;
Poxton, I. .
CLINICAL MICROBIOLOGY AND INFECTION, 2007, 13 (11) :1048-1057
[2]  
BOLTON RP, 1980, LANCET, V1, P383
[3]   Definition of the single integration site of the pathogenicity locus in Clostridium difficile [J].
Braun, V ;
Hundsberger, T ;
Leukel, P ;
Sauerborn, M ;
vonEichelStreiber, C .
GENE, 1996, 181 (1-2) :29-38
[4]   PCR AMPLIFICATION OF RIBOSOMAL-RNA INTERGENIC SPACER REGIONS AS A METHOD FOR EPIDEMIOLOGIC TYPING OF CLOSTRIDIUM-DIFFICILE [J].
CARTWRIGHT, CP ;
STOCK, F ;
BEEKMANN, SE ;
WILLIAMS, EC ;
GILL, VJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (01) :184-187
[5]   tcdC genotypes associated with severe TcdC truncation in an epidemic clone and other strains of Clostridium difficile [J].
Curry, Scott R. ;
Marsh, Jane W. ;
Muto, Carlene A. ;
O'Leary, Mary M. ;
Pasculle, A. William ;
Harrison, Lee H. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (01) :215-221
[6]   High-level resistance to moxifloxacin and gatifloxacin associated with a novel mutation in gyrB in toxin-A-negative, toxin-B-positive Clostridium difficile [J].
Drudy, Denise ;
Quinn, Teresa ;
O'Mahony, Rebecca ;
Kyne, Lorraine ;
O'Gaora, Peadar ;
Fanning, Seamus .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (06) :1264-1267
[7]   A modified pulsed-field get electrophoresis (PFGE) protocol for subtyping previously non-PFGE typeable isolates of Clostridium difficile polymerase chain reaction ribotype 001 [J].
Gal, M ;
Northey, G ;
Brazier, JS .
JOURNAL OF HOSPITAL INFECTION, 2005, 61 (03) :231-236
[8]   Distribution of Clostridium difficile variant toxinotypes and strains with binary toxin genes among clinical isolates in an American hospital [J].
Geric, B ;
Rupnik, M ;
Gerding, DN ;
Grabnar, M ;
Johnson, S .
JOURNAL OF MEDICAL MICROBIOLOGY, 2004, 53 (09) :887-894
[9]   CLOSTRIDIUM-DIFFICILE AND INFLAMMATORY BOWEL-DISEASE [J].
GREENFIELD, C ;
RAMIREZ, JRA ;
POUNDER, RE ;
WILLIAMS, T ;
DANVERS, M ;
MARPER, SR ;
NOONE, P .
GUT, 1983, 24 (08) :713-717
[10]   Review:: Clostridium difficile-associated disorders/diarrhea and Clostridium difficile colitis:: The emergence of a more virulent era [J].
Hookman, Perry ;
Barkin, Jamie S. .
DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (04) :1071-1075